Intending to raise funds and enhance business, various companies have planned to be listed in the stock exchange, wherein SME IPO would be launched on the NSE or BSE, and Mainboard IPO will be on both the BSE and NSE stock exchanges.
All types of investors are being advised to evaluate fundamentals, issue pricing, and overall market conditions before applying.
| IPO name | Opening date | Closing Date | Issue Size | Issue Price | IPO listing |
| Goldline Pharmaceutical | May 12, 2026 | May 14, 2026 | ā¹12 Cr. | ā¹41 to ā¹43 | May19, 2026 |
| RFBL Flexi Pack | May 12, 2026 | May 14, 2026 | ā¹35 Cr. | ā¹47 to ā¹50 | May 19, 2026 |
Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO opens on May 12, 2026, and closes on May 14, 2026. The Company plans to raise around ā¹11.61 crores via a fresh issue with no Offer-for-Sale component with a face value of ā¹10 each. Goldline Pharmaceutical IPO to list on BSE SME on May 19, 2026. Goldline Pharmaceutical’s IPO price band is ā¹41 to ā¹43 per share.
RFBL Flexi Pack IPOĀ
RFBL Flexi Pack IPO opens on May 12, 2026, and closes on May 14, 2026. The company plans to raise ā¹35.33 crores via IPO, which comprises a fresh issue of ā¹35.33 crores with no Offer-for-Sale component, with a face value of ā¹10 each. RFBL Flexi Pack IPO to list on NSE SME on May 19, 2026. RFBL Flexi Pack IPO price band is ā¹47 to ā¹50 per share.
Note: This news article is created only for educational purposes. It is not meant as an approval or recommendation to invest in any securities. Investors should conduct their research and get advice from financial advisors before making any investment decisions. Please keep in mind that GMP (Grey Market Premium) values also.
